X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bay 94-8862 (49) 49
index medicus (41) 41
humans (36) 36
chronic heart-failure (27) 27
spironolactone (22) 22
finerenone (21) 21
double-blind (20) 20
aldosterone (19) 19
chronic kidney-disease (18) 18
animals (17) 17
heart failure (17) 17
mineralocorticoid receptor antagonists - therapeutic use (17) 17
pharmacology & pharmacy (17) 17
eplerenone (16) 16
mineralocorticoid receptor (15) 15
antagonist (12) 12
hypertension (12) 12
male (12) 12
heart failure - drug therapy (11) 11
cardiac & cardiovascular systems (10) 10
diabetic-nephropathy (10) 10
hyperkalemia (10) 10
mineralocorticoid receptor antagonist (10) 10
mineralocorticoid receptor antagonists (10) 10
mineralocorticoid receptor antagonists - pharmacology (10) 10
naphthyridines - therapeutic use (10) 10
receptors, mineralocorticoid - metabolism (9) 9
spironolactone - analogs & derivatives (9) 9
mineralocorticoid receptor antagonists - adverse effects (8) 8
left-ventricular dysfunction (7) 7
middle aged (7) 7
myocardial-infarction (7) 7
naphthyridines - adverse effects (7) 7
renal insufficiency, chronic - drug therapy (7) 7
renin-angiotensin system - drug effects (7) 7
task-force (7) 7
urology & nephrology (7) 7
aged (6) 6
blood-pressure (6) 6
cardiovascular disease (6) 6
chronic kidney disease (6) 6
diabetic kidney disease (6) 6
diabetic nephropathies - drug therapy (6) 6
female (6) 6
heart (6) 6
heart-failure (6) 6
mineralocorticoid receptor antagonists - pharmacokinetics (6) 6
naphthyridines - pharmacology (6) 6
peripheral vascular disease (6) 6
spironolactone - pharmacology (6) 6
steroids (6) 6
tolerability (6) 6
treatment outcome (6) 6
albuminuria (5) 5
albuminuria - drug therapy (5) 5
angiotensin receptor antagonists - therapeutic use (5) 5
angiotensin-aldosterone system (5) 5
antihypertensive agents - therapeutic use (5) 5
chemistry, medicinal (5) 5
chronic kidney failure (5) 5
discovery (5) 5
double-blind method (5) 5
hyperkalemia - chemically induced (5) 5
hypertension - drug therapy (5) 5
kidney diseases (5) 5
pharmacokinetics (5) 5
potent (5) 5
safety (5) 5
activation (4) 4
administration, oral (4) 4
adult (4) 4
angiotensin-converting enzyme inhibitors - therapeutic use (4) 4
cardiology (4) 4
care and treatment (4) 4
dose-response relationship, drug (4) 4
endocrinology & metabolism (4) 4
fibrosis (4) 4
kidney-disease (4) 4
mice (4) 4
mild patients hospitalization (4) 4
mineralocorticoid receptor antagonists - chemistry (4) 4
naphthyridines - pharmacokinetics (4) 4
pharmacology (4) 4
rats (4) 4
renal-function (4) 4
selective aldosterone blocker (4) 4
signal transduction - drug effects (4) 4
trial (4) 4
aldosterone antagonists (3) 3
aldosterone blockade (3) 3
angiotensin (3) 3
arts (3) 3
binding (3) 3
blockade (3) 3
blood pressure - drug effects (3) 3
brain natriuretic peptide (3) 3
cardiorenal injury (3) 3
chronic disease (3) 3
clinical trials as topic (3) 3
converting enzyme-inhibitor (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ChemMedChem, ISSN 1860-7179, 08/2012, Volume 7, Issue 8, pp. 1385 - 1403
Journal Article
JAMA, ISSN 0098-7484, 09/2015, Volume 314, Issue 9, pp. 884 - 894
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 02/2018, Volume 61, Issue 3, pp. 1086 - 1097
A novel series of morpholine-based non steroidal mineralocorticoid receptor antagonists is reported. Starting from a pyrrolidine HTS hit 9 that possessed... 
HEART | DESIGN | CHEMISTRY, MEDICINAL | SPIRONOLACTONE | DRUG DISCOVERY | BAY 94-8862 | DIABETIC-NEPHROPATHY | ALDOSTERONE | HIGHLY POTENT | DERIVATIVES | RECEPTOR ANTAGONIST | Index Medicus
Journal Article
Journal of Endocrinology, ISSN 0022-0795, 07/2017, Volume 234, Issue 1, pp. T125 - T140
Journal Article
JOURNAL OF DIABETES AND ITS COMPLICATIONS, ISSN 1056-8727, 04/2017, Volume 31, Issue 4, pp. 758 - 765
Aims: Finerenone (BAY 94-8862) is a novel non-steroidal mineralocorticoid receptor antagonist. The aim of this study was to compare the efficacy and safety of... 
Type 2 diabetes | CHRONIC HEART-FAILURE | ANTAGONIST | RENAL-DISEASE | Albuminuria | Finerenone | MINERALOCORTICOID RECEPTOR | SPIRONOLACTONE | ALDOSTERONE BLOCKADE | BAY 94-8862 | ENDOCRINOLOGY & METABOLISM | Diabetic nephropathy | CHRONIC KIDNEY-DISEASE | EPLERENONE | MRA
Journal Article
HYPERTENSION, ISSN 0194-911X, 04/2018, Volume 71, Issue 4, pp. 599 - 608
Journal Article
Medicine, ISSN 0025-7974, 04/2018, Volume 97, Issue 16, pp. e0254 - e0254
Background: The non-steroidal mineralocorticoid receptor antagonist finerenone (BAY 94-8862) has been used to treat chronic heart failure (CHF) with reduced... 
MILD | heart failure | MEDICINE, GENERAL & INTERNAL | POTENT | finerenone | safety | SPIRONOLACTONE | HYPERKALEMIA | BAY 94-8862 | DOUBLE-BLIND | VS. EPLERENONE | efficacy | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 2018, Volume 33, Issue 12, pp. 2080 - 2091
Journal Article
Journal of Molecular and Cellular Cardiology, ISSN 0022-2828, 08/2018, Volume 121, pp. 124 - 133
Journal Article
EUROPEAN JOURNAL OF HEART FAILURE, ISSN 1388-9842, 02/2015, Volume 17, Issue 2, pp. 224 - 232
Journal Article
Journal Article
Journal Article
18.